Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

The following is a brief description of the relevant columns in the table below (by column header):

The following is a brief description of the relevant columns in the table below (by column header):

column name: name as it should appear in data portal

current synapse

...

file view column: corresponding name (e.g., for SQL query) in Synapse table view

...

eventual synapse file view column: name (e.g., for SQL query) in Synapse table view that we will eventually migrate to

difference between current and eventual columns: as we migrate to GDC, we will put new annotation keys in "eventual" column names. for now, use "current."

facet: true if column_name should be faceted in data portal.

card location: primary (i.e., top) or secondary (i.e., bottom) key/annotation

...

desired for CSBC/PS-ON: should this column be included in the CSBC data portal

...

The following annotations do not exist on file: 

The following annotations need to be "ported" to GDC:  

The following have been added to the synapse table, but are blank. They need to be filled in:

column namecurrent synapse file view columneventual synapse file view columnfacetcard locationconceptexamplerequiredcolumn typeGDC equivalentfaceted on GDCfacet on CSBCGDC referencesizerestricted valuescommentsin AMP-AD portalin NF portaldesired for CSBC/PS-ON
Grant Type

yesNA
U54 or U01








Grant

yesNA










Program

yesNA
CSBC or PSON








Speciesspeciesspeciesyessecondary

none
yes





Scientific ThemeNAthemeyessecondary (or possibly pill directly beneath file name)
tumor-heterogeneitynone
yes





Data Categoryassaydata_categoryyessecondaryBroad categorization of the contents of the data file.
  • Transcriptome Profiling
data_categoryyesyes


CSBC will need to add values to those in GDC (which only cover sequencing)

Experiment Strategyassayexperimental_strategyyessecondaryThe sequencing strategy used to generate the data file.  REMOVE "sequencing" for CSBC.
  • RNA-Seq
  • Total RNA-Seq
experimental_strategyyesyes


CSBC will need to add values to those in GDC (which only cover sequencing)

Platform

yesNA

platformyesyes





Disease Type

yessecondaryThe text term used to describe the type of malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Acinar Cell Neoplasms
  • Adenomas and Adenocarcinomas
  • Adnexal and Skin Appendage Neoplasms
  • Basal Cell Neoplasms
  • Blood Vessel Tumors
case/disease_typeyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=case




Site

yessecondaryThe text term used to describe the general location of the malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Accessory sinuses
  • Adrenal gland
  • Anus and anal canal
  • Base of tongue
  • Bladder
case/primary_siteyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=case




Tissue

yessecondaryThe text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Abdomen, NOS
  • Abdominal esophagus
  • Accessory sinus, NOS
  • Acoustic nerve
  • Adrenal gland, NOS
diagnosis/tissue_or_organ_of_originyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis